De Clercq E

References (3)

Title : Topical treatment of acute adenoviral keratoconjunctivitis with 0.2\% cidofovir and 1\% cyclosporine: a controlled clinical pilot study - Hillenkamp_2001_Arch.Ophthalmol_119_1487
Author(s) : Hillenkamp J , Reinhard T , Ross RS , Bohringer D , Cartsburg O , Roggendorf M , De Clercq E , Godehardt E , Sundmacher R
Ref : Archives of Ophthalmology , 119 :1487 , 2001
Abstract : Hillenkamp_2001_Arch.Ophthalmol_119_1487
ESTHER : Hillenkamp_2001_Arch.Ophthalmol_119_1487
PubMedSearch : Hillenkamp_2001_Arch.Ophthalmol_119_1487
PubMedID: 11594949

Title : Intracellular metabolism of CycloSaligenyl 3'-azido-2', 3'-dideoxythymidine monophosphate, a prodrug of 3'-azido-2', 3'-dideoxythymidine (zidovudine) - Balzarini_1999_Mol.Pharmacol_56_1354
Author(s) : Balzarini J , Naesens L , Aquaro S , Knispel T , Perno C , De Clercq E , Meier C
Ref : Molecular Pharmacology , 56 :1354 , 1999
Abstract : Balzarini_1999_Mol.Pharmacol_56_1354
ESTHER : Balzarini_1999_Mol.Pharmacol_56_1354
PubMedSearch : Balzarini_1999_Mol.Pharmacol_56_1354
PubMedID: 10570065

Title : 9-(2-Phosphonylmethoxyethyl)adenine induces tumor cell differentiation or cell death by blocking cell cycle progression through the S phase - Hatse_1999_Cell.Growth.Differ_10_435
Author(s) : Hatse S , Schols D , De Clercq E , Balzarini J
Ref : Cell Growth Differ , 10 :435 , 1999
Abstract : Hatse_1999_Cell.Growth.Differ_10_435
ESTHER : Hatse_1999_Cell.Growth.Differ_10_435
PubMedSearch : Hatse_1999_Cell.Growth.Differ_10_435
PubMedID: 10392905